Thrombopoietin Receptor

The thrombopoietin receptor also known as the myeloproliferative leukemia protein or CD110 (Cluster of Differentiation 110) is a protein that in humans is encoded by the MPL (myeloproliferative leukemia virus) oncogene.

Cat. No.	製品名	CAS No.	Purity
T3882	4”-O-Glucosylvitexin	76135-82-5	98%
T3882	4”-O-Glucosylvitexin (glucosylvitexin) inhibits TPO activity.
T67894	Butyzamide	1110767-45-7	100%
T67894	Butyzamide is an effective and oral Mpl activator. It is a novel non-peptide-based molecule with antagonistic effects on thrombopoietin (TPO) receptors, which pr...
T7417	Avatrombopag	570406-98-3	99.41%
T7417	Avatrombopag (YM477) is a new oral thrombopoietin (TPO) receptor agonist, activating TPO receptor and increasing megakaryocytic proliferation/differentiation and...
TQ0223	Lusutrombopag	1110766-97-6	99.74%
TQ0223	Lusutrombopag (Mulpleta) is an orally bioavailable, small molecule thrombopoietin (TPO) receptor agonist for chronic liver disease (CLD) patients with thrombocyt...

4”-O-Glucosylvitexin

T3882

4”-O-Glucosylvitexin (glucosylvitexin) inhibits TPO activity.

Butyzamide

T67894

Butyzamide is an effective and oral Mpl activator. It is a novel non-peptide-based molecule with antagonistic effects on thrombopoietin (TPO) receptors, which pr...

Avatrombopag

T7417

Avatrombopag (YM477) is a new oral thrombopoietin (TPO) receptor agonist, activating TPO receptor and increasing megakaryocytic proliferation/differentiation and...

Lusutrombopag

TQ0223

Lusutrombopag (Mulpleta) is an orally bioavailable, small molecule thrombopoietin (TPO) receptor agonist for chronic liver disease (CLD) patients with thrombocyt...

本ウェブサイトに掲載されている製品は全て研究用試薬です。研究目的以外の用途にはご使用できません。